John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

With numerous companies investing in novel primary immune deficiency therapies, the pharmaceutical product launch of emerging treatments is expected to reshape the competitive landscape significantly.

announces the launch of Carrier Lynx FacTOR™, a revolutionary software-as-a-service (SaaS) solution designed to transform product release processes in the pharmaceutical industry. Lynx FacTOR ...

Q4 2024 Management View Richard Lowenthal, Co-Founder and CEO, highlighted the successful launch of neffy 2mg in the U.S. and the FDA approval for neffy 1mg for pediatric use, targeting children ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today ...

SaaS solution minimizes manual processes, accelerates batch release cycles and meets regulatory compliance* Pharmaceutical companies face numerous challenges in ensuring product integrity ...